Abstract
We have cloned and characterized a novel murine Ste20-related kinase designated SLK. SLK displays high homology to the Ste20-related kinase LOK, and is more distantly related to MST1 and 2, both Ste20-like kinases. In addition, SLK displays high homology to microtubule and nuclear associated protein (M-NAP) and AT1-46, both of unknown function. SLK is ubiquitously expressed as multiple mRNAs in tissues and cell lines and is downregulated by mitogen depletion in differentiating myoblasts. Biochemical characterization showed that SLK overexpression activates c-Jun amino-terminal kinase 1 (JNK1). However, in vitro kinase assays indicated that SLK was not activated in response to various growth factors or stress-inducing agents. Immunofluorescence studies revealed that SLK colocalized to distinct cytosolic domains, preferentially at the periphery of the cells. In addition, prolonged overexpression of SLK in cultured fibroblasts resulted in apoptosis as demonstrated by annexin-V and TUNEL staining. Our results suggest that SLK belongs to a new family of protein kinases, mediating activation of the stress response pathway through a novel signaling cascade.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Creasy CL and Chernoff J. . 1995 Gene 167: 303–306.
Davis RJ. . 1993 J. Biol. Chem. 268: 14553–14556.
Fanger GR, Gerwins P, Widmann C, Jarpe MB and Johnson GL. . 1997 Curr. Opin. Genet. Dev. 7: 67–74.
Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DK, Wright M, Chernoff J, Clark EA and Krebs EG. . 1998 EMBO J. 17: 2224–2234.
Hanks SK and Hunter T. . 1995 FASEB J. 9: 576–596.
Hughes DA. . 1995 Semin. Cell. Biol. 6: 89–94.
Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y. . 1997 Science 275: 90–94.
Itoh S, Kameda Y, Yamada E, Tsujikawa K, Mimura T and Kohama Y. . 1997 Arch. Biochem. Biophys. 340: 201–207.
Katoh M, Hirai M, Sugimura T and Terada M. . 1995 Oncogene 10: 1447–1451.
Kawai T, Matsumoto M, Takeda K, Sanjo H and Akira S. . 1998 Mol. Cell. Biol. 18: 1642–1651.
Kerr JF, Wyllie AH and Currie AR. . 1972 Br. J. Cancer 26: 239–257.
Kuramochi S, Moriguchi T, Kuida K, Endo J, Semba K, Nishida E and Karasuyama H. . 1997 J. Biol. Chem. 272: 22679–22684.
Leberer E, Thomas DY and Whiteway M. . 1997a Curr. Opin. Genet. Dev. 7: 59–66.
Leberer E, Wu C, Leeuw T, Fourest-Lieuvin A, Segall JE and Thomas DY. . 1997b EMBO J. 16: 83–97.
Olson EN and Klein WH. . 1994 Genes Dev. 8: 1–8.
Pawson T and Scott JD. . 1997 Science 278: 2075–2080.
Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y and Jacobson MD. . 1993 Science 262: 695–700.
Ross J. . 1996 Trends Genet. 12: 171–175.
Sambrook J, Fritsch EF and Maniatis T. . 1989 Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
Schaar DG, Varia MR, Elkabes S, Ramakrishnan L, Dreyfus CF and Black IB. . 1996 Brain Res. 721: 217–228.
Schinkmann K and Blenis J. . 1997 J. Biol. Chem. 272: 28695–28703.
Stanger BZ, Leder P, Lee TH, Kim E and Seed B. . 1995 Cell 81: 513–523.
Steller H. . 1995 Science 267: 1445–1449.
Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN. . 1996 Nature 380: 75–79.
Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. . 1995 Science 270: 1326–1331.
Yang X, Khosravi-Far R, Chang HY and Baltimore D. . 1997 Cell 89: 1067–1076.
Zhao ZS, Leung T, Manser E and Lim L. . 1995 Mol. Cell. Biol. 15: 5246–5257.
Acknowledgements
We thank Catherine Neville and Robert Korneluk for sequencing cDNAs. This work was supported by grants from the Medical Research Council of Canada and the National Institutes of Health to MA Rudnicki. LA Sabourin is supported by a post-doctoral fellowship from the Medical Research Council of Canada. MA Rudnicki is a Research Scientist of the Medicar Research Council of Canada.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabourin, L., Rudnicki, M. Induction of apoptosis by SLK, a Ste20-related kinase. Oncogene 18, 7566–7575 (1999). https://doi.org/10.1038/sj.onc.1203119
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203119
Keywords
This article is cited by
-
SEPepQuant enhances the detection of possible isoform regulations in shotgun proteomics
Nature Communications (2023)
-
Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness
Skeletal Muscle (2017)
-
Distinct roles for Ste20-like kinase SLK in muscle function and regeneration
Skeletal Muscle (2013)
-
The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility
Oncogene (2009)
-
The mammalian family of sterile 20p-like protein kinases
Pflügers Archiv - European Journal of Physiology (2009)